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Pulse oximetry screening for congenital heart defects in
Switzerland: most but not all maternity units screen their neonate
Abstract
QUESTIONS: In Switzerland, the screening of neonates for congenital heart defects (CHD) by using
pulse oximetry (PO) on the first day of life was recommended in 2005. We assessed the current practice
of Swiss maternity units regarding PO screening to define the actual screening rate in Switzerland and to
detect possible difficulties in the implementation of this screening. METHODS: This descriptive study
was conducted by means of a standardized questionnaire that was sent to all Swiss maternity units.
RESULTS: The response rate was 100%. 76% of the units perform regular PO screening and, on the
basis of the number of births for 2007, this means that 85% of newborns in Switzerland undergo
screening. Although units which do not perform PO screening include every category of maternity unit,
the screening is performed to a significantly lower extent in birthing centres than in hospitals (p <0.001).
The number of unscreened neonates was 5398 within small units (<1000 births per year) while it was
6137 within large units (>1000 births per year). The main reasons for not performing PO screening are
financial factors and the belief that clinical signs are sufficient for the detection of CHD.
CONCLUSIONS: Greater effort is needed to implement a nationwide PO screening program for CHD.
Special attention should be paid to birthing centres given their limited capacity to treat newborns with
critical CHD.
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Questions: In Switzerland, the screening of
neonates for congenital heart defects (CHD) by
using pulse oximetry (PO) on the first day of life
was recommended in 2005. We assessed the cur-
rent practice of Swiss maternity units regarding
PO screening to define the actual screening rate
in Switzerland and to detect possible difficulties
in the implementation of this screening.
Methods: This descriptive study was con-
ducted by means of a standardized questionnaire
that was sent to all Swiss maternity units.
Results: The response rate was 100%. 76% of
the units perform regular PO screening and, on
the basis of the number of births for 2007, this
means that 85% of newborns in Switzerland un-
dergo screening. Although units which do not
perform PO screening include every category of
maternity unit, the screening is performed to a
significantly lower extent in birthing centres than
in hospitals (p <0.001). The number of un-
screened neonates was 5398 within small units
(<1000 births per year) while it was 6137 within
large units (>1000 births per year). The main rea-
sons for not performing PO screening are finan-
cial factors and the belief that clinical signs are
sufficient for the detection of CHD. 
Conclusions: Greater effort is needed to imple-
ment a nationwide PO screening program for
CHD. Special attention should be paid to
birthing centres given their limited capacity to
treat newborns with critical CHD.
Key words: congenital heart defects; echocardiogra-
phy; pulse oximetry; screening; neonate; recommenda-
tions
Summary
Congenital heart defects (CHD) are the most
frequent congenital malformation, with an inci-
dence of 6 to 8 per 1000 live births. Nowadays,
even complex CHD can be treated with the ap-
propriate surgical or catheter intervention.
Timely recognition is crucial for a good outcome,
but can be challenging in neonates because of an
initial lack of specific clinical signs. Ductus-de-
pendent CHD, such as hypoplastic left heart syn-
drome or transposition of the great arteries, may
be clinically recognizable only after spontaneous
closure of the arterial duct. This is followed by a
rapid progression of severe low cardiac output
and/or cyanosis and deterioration of the patient.
As severe cardiovascular compromise is related
significantly to mortality and prolonged ventila-
tion [1], timely detection prior to closure of the
duct in this population is important. Patients with
right-to-left shunting, which is either intracardiac
or at the level of the patent arterial duct, have a
decreased postductal oxygen saturation. This can
be measured by pulse oximetry (PO) on the pa-
tient’s feet. PO screening has been shown to be
effective in the detection of CHD with a high
specificity of over 99% and a sensitivity of 72% to
77% [2–4].
On the basis of this evidence, the Swiss Soci-
ety of Neonatology and the Swiss Society of Pae-
diatric Cardiology recommended, in 2005, that all
neonates born in Switzerland should be screened
on their first day of life by using transcutaneous
PO on a foot. If the saturation is below 95%, the
guidelines outlined in figure 1 should then be fol-
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lowed. According to these guidelines, patients sat-
isfying certain criteria should receive an echocar-
diography exam to find out if they have CHD.
The official journal of the Swiss Paediatric Soci-
ety published these recommendations in 2005 [5],
in order to notify as many maternity units as pos-
sible. The chairwoman of the Swiss Association of
Midwives was also informed of these recommen-
dations.
Different studies have recently defined (or are
still investigating) the specificity and sensitivity of
this screening in larger populations as well as its
cost effectiveness [3, 4, 6, 7]. The intention of this
survey was not to demonstrate the effectiveness of
PO screening. In contrast, our aim was to evaluate
the current acceptance and the practicability of
the implementation of PO screening, as judged
by the maternity units. 
Our hypothesis was that most maternity units
in Switzerland followed the recommendations,
and that no adaptations to the screening protocol
had been made. 
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Methods
Data acquisition
In summer 2008, a structured questionnaire was sent
to all 136 registered maternity units in Switzerland. The
head of each maternity unit was asked to answer the fol-
lowing questions: 
– In your centre, do you carry out pulse oximetry screen-
ing in accordance with the recommendations of the
Swiss Society of Neonatology, Paediatrics, and Paedi-
atric Cardiology? 
– Did you have to adapt the protocol? 
The questionnaire was translated into the three main
official languages of Switzerland. If there was no reply
after two weeks, a reminder was sent via e-mail, and in the
absence of a reaction after four weeks, the centre was con-
tacted by phone, with the questionnaire being sent again,
if necessary. 
Data analysis
The results were set against the total number of
newborns per centre in 2007. These numbers were ob-
tained from the annual birth-statistics report, based on
declarations submitted by the maternity units them-
selves [8].
In order to assess the influence of the size of the as-
sociated paediatric unit on the screening rates, we
grouped the maternity units into three categories accord-
ing to the level of paediatrics training available at this as-
sociated centre: (1) maternity units associated with terti-
Obtain PO at foot during first day of life
in sleeping/quiet neonate
Note highest value
as soon as there is a good pulse wave
PO ≥95% PO 90–94%
Perform a careful
clinical examination
No suspicion of CHD
in clinical exam
Suspicion of CHD
in clinical exam
Repeat PO
some hours later
PO ≥95%
No echocardiography unless:
– Conspicuous clinical exam*
– Positive family history†
– Wish of very anxious parents
PO <95%
Obtain echocardiography
PO <90%
Clinical suspicion
of CHD*
Figure 1
Flowchart of the
 recommendations 
for pulse oximetry
(PO) screening in
neonates (adapted
from Arlettaz et al. [5]).
* Suspicious cardiac
clinical examination;
syndrome with dys-
morphism or multiple
congenital malforma-
tions.
† Congenital heart
disease in first-de-
gree relative; mater-
nal diabetes; mater-
nal drug or alcohol
abuse; confirmed
prenatal diagnosis 
of CHD.
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ary care centres for paediatrics, (2) maternity units with
secondary or primary care centres for paediatrics, and (3)
maternity units without paediatric units, such as small re-
gional hospitals or private services. The categories were
adopted from the official grouping of paediatric units
drawn up by the Swiss Medical Association [9]. 
To compare screening rates with regard to the kind
of maternity unit, we categorised the latter as follows: (1)
birthing centres (“Geburtshäuser”), (2) private hospitals,
and (3) public hospitals.
The screening rates were also compared against the
size of the maternity units. For this purpose, we classified
the maternity units as follows: (1) very small units with
100 or fewer births per year in 2007, (2) small units with
over 100 to 500 births per year, (3) medium-sized units
with over 500 to 1000 births per year, and (4) large units
with over 1000 births per year.
The allocation of the maternity units to a language
region was performed on the basis of the main official
language spoken in the locality in question, so as to high-
light potential differences between these regions. 
The statements given by maternity units for not
adopting PO screening were summarised under general
headings. When multiple answers were given, all the
statements were noted. 
The data collected from the units was analysed by
means of descriptive statistics. Comparisons were made
using the chi-square test. Logistic regression analysis was
used to test for possible interactions between different
variables. For that purpose we employed the answer to
the PO screening question as the dependent variable and
the existence of a paediatric unit, the size (over 100 vs 100
or fewer births a year), and the kind of obstetric unit
(hospital vs birthing centre) as covariates.
P-values <0.05 were considered significant. SPSS
version 16.0 for Windows was employed for statistical
analysis.
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Results
The response rate to the questionnaire was
100% within 10 weeks. 
Of the 136 maternity units approached, 103
(76%) actually perform the screening as recom-
mended. Scaling this figure according to the num-
ber of births per maternity unit in 2007 gives the
result that 85% of all neonates born in Switzer-
land are screened. 
In maternity units linked to a paediatric unit,
the percentage of hospitals performing PO
screening is significantly higher than in maternity
units without a paediatric unit (p = 0.019). There
is no significant difference in the screening rates
for tertiary and secondary or primary paediatric
care centres (p = 0.061).
When the maternity units are categorised
 according to their obstetric facilities, a lower level
of screening is found in birthing centres than in
obstetric units in hospitals (15% vs 86%, respec-
tively; p <0.001). Private hospitals have the high-
est rate of regular PO screening of all categories
(fig. 2), but the screening rates at private and pub-
lic hospitals do not differ significantly (p = 0.125). 
As is shown in figure 3, maternity units with
100 or fewer births a year screen significantly less
than maternity units with more than 100 births
per year (p <0.001). However, the largest Swiss
birth clinic, with nearly 4000 births per year, does
not perform the screening – being the only Swiss
perinatal centre not to do so. Screening rates in
the three categories of centre with over 100 births
per year do not differ significantly from each
other (p = 0.169). If these data are looked at from a
more infant-based view, the number of un-
Figure 2
Screening rate by category of maternity unit; n = 136
(birthing centre: n = 20; private hospital: n = 24; public hos-
pital: n = 92). Percentage (indexed on the left) of units with
regular PO screening (white) and without (grey).
Figure 3
Screening rate by size of maternity unit (n = 136). Percent-
age (indexed on the left) of units with regular PO screening
(white) and without (grey). Size is categorised as very small
(<=100 births/year; n = 25), small (>100–500 births/year; 
n = 49), medium-sized (>500–1000 births/year; n = 44), 
and large (>1000 births/year; n = 18). 
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screened neonates was 5398 for the 30 birth
places with less than 1000 births per year while it
was 6137 in the 3 birth places with more than
1000 births per year.
With regard to the three language regions, we
found that all maternity units in the Italian-speak-
ing (southern) part of Switzerland perform the
screening, whereas screening rates in the Ger-
man-speaking part and the French-speaking part
are lower (100%, 77.2% and 64.3%, respectively).
These screening rates do not, however, differ sig-
nificantly from each other (p = 0.113). 
The category of the maternity unit (i.e., hos-
pital vs birthing centre) was the only independent
variable that produced significant results in a uni-
variate analysis, as was shown by a logistic regres-
sion analysis of the three subdivisions (i.e., the
size of the paediatric unit, and the size and cate-
gory of maternity unit).
The most commonly given reasons for not
carrying out the screening are financial factors
and the belief that clinical signs are sufficient for
detecting CHD (table 1). A third of maternity
units that do not perform the screening (11/33)
state that they do not own a pulse oximeter
and/or they cannot afford one. All but two of
these are birthing centres and are very small (me-
dian 20, range 3 to 91 births per year in 2007). All
maternity units performing the screening fol-
lowed the recommendations without any modifi-
cations. 
702PO screening for CHD in Switzerland
Stated reasons Number of 
maternity 
units
Financial factors, costs 14
Clinical presentation is sufficient to detect CHD 11
No in-house guidelines available 4
Recommendations are not evidence-based 2
We will have adopted screening by the end of 2008 2
No answer given 4
Table 1
Reasons for not per-
forming pulse oxime-
try (PO) screening.
Answers given by the
33 out of 136 mater-
nity units who do not
perform PO screen-
ing. Multiple answers
possible.
Discussion
This survey is based on a standardised ques-
tionnaire and showed an excellent rate of return.
It provides a representative overview of the cur-
rent opinion and practice of all Swiss maternity
units with regard to PO screening. The results of
this survey provide a sound basis for discussing
possible further measures to be taken to promote
the spread of PO screening in Switzerland. Fur-
thermore, it has the potential to provide other
countries that are planning to implement a
screening program with a list of the problems that
were encountered in the implementation of the
screening program in Switzerland. This should
help these other countries anticipate and, there-
fore, prevent similar problems.
The benefit of PO screening is still a subject
of controversy. Sendelbach et al. [6] found no
 additional benefit of PO screening when prenatal
ultrasound, close clinical observation during the
first few hours, and physical examination were
used. In contrast, de-Wahl Granelli et al. [4]
found a higher sensitivity with the combination of
examination and oximetry screening than with ei-
ther of the methods individually. Similar findings
have been reported by Meberg et al. [3]. In a na-
tional Norwegian study they also found a trend
for fewer critical heart defects to be missed and
detected after discharge in the population under-
going PO screening [10]. As most maternity units
in Switzerland use rooming-in and do not have
the space or staff to closely observe all newborns,
we strongly believe that neonates born in Switzer-
land do indeed benefit from PO screening. In-
creasing numbers of newborns are discharged
sooner after delivery and this trend may further
increase the benefit of PO screening, as clinical
signs of CHD may not yet be present by the time
of the physical examination if the arterial duct is
still open. The potential detection of patients with
very early potentially severe pulmonary disease
and infection with subclinical or subtle symptoms
is an additional advantage of the screening [3].
The estimated screening rate of 85% of all
newborns in our study population is similar to re-
cently published data of 75% to 86% from studies
in other countries [3, 7]. The variability of the
screening rates in different studies and countries
can be explained by the rigidity of the respective
recommendations and whether parental consent
is required or not. Given that PO screening is rec-
ommended by all the sub-specialty societies in
Switzerland, and since there is no additional
charge for parents, a screening rate in excess of
90% ought to be expected.
A pulse oximeter unit forms part of the stan-
dard equipment of all maternity units in Switzer-
land [11], and an appropriate device can be pur-
chased by any centre at a low cost. In our experi-
ence, PO can be used on a sleeping newborn and
is not a time-consuming procedure. It will usually
take no longer than five minutes to obtain an
 appropriate reading, and no additional staff are
needed [4, 12]. As none of the maternity units
made any modifications to the recommended
screening procedure, it can be stated that this can
be readily integrated in the clinical routine. Some
smaller maternity units do not measure the trans -
cutaneous saturation in order to avoid disturbing
the neonate and upsetting or worrying the family
with unnecessary tests. Although the psychosocial
effects of PO screening among parents still have
to be explored, the clear benefits of early detec-
699-704 Kuelling 12880.qxp  20.11.2009  12:05 Uhr  Seite 702
703
tion of a potentially lethal CHD far outweigh any
such concerns, so this approach cannot be sup-
ported. Furthermore, most of these maternity
units are remote from tertiary care centres and do
not employ a paediatrician. Neonates born in
these places benefit most from the early recogni-
tion of critical CHD to ensure that they do not
suffer delayed admission to a paediatric clinic. 
A majority of patients with relevant CHD will
be detected by a careful clinical examination per-
formed within the first few days of life [2, 6]. The
timing of the transition from fetal to postnatal
circulation is highly variable, and the arterial duct
may remain patent for more than 72 hours even
in full-term infants [13]. Therefore, as many as
20–25% of newborns with a critical heart malfor-
mation may leave the maternity ward without the
diagnosis being made [14–16]. This finding illus-
trates the inadequate sensitivity achieved by just
using clinical examination to detect CHD. If
CHD is recognised at a later stage, i.e., when a
cardiovascular compromise occurs, the outcome
following heart surgery has been shown to be
worse [1]. PO performed in addition to the clini-
cal examination has been shown to improve the
detection rate of critical CHD [3, 4, 12, 17–19],
and to detect CHD earlier [10].
Our plan for further improving the screening
rate is as follows: maternity units not performing
the screening are being approached directly in
order to encourage the implementation of PO
screening as part of their routine postnatal care.
The results of this study have been presented to
the chairwoman of the Swiss Association of Mid-
wives and her help has been requested to improve
the acceptability of PO in birthing centres. Low-
volume maternity units, who stated financial fac-
tors as a reason for not screening, are being indi-
vidually approached, and the possibilities of exter-
nal funding are being discussed. Maternity units
which do not have in-house guidelines are being
provided with the relevant documentation and
advised of the official recommendations. 
The conclusions drawn from this survey are
limited by the fact that data were collected retro-
spectively. The total screening rate of 85% might
be slightly overestimated, because some neonates
might have escaped from the screening although
they were born in maternity units which stated
that they perform regular PO screening. We did
not assess how PO readings were obtained in the
different maternity units nor which training the
person performing the screening had obtained.
Both these factors have been found to influence
the reliability and therefore the sensibility of PO
screening [20]. Another effect of the retrospective
design is that values of PO results and concomi-
tant diagnoses could not be obtained. Likewise,
the number of neonates ineligible for screening,
for example in the case of prenatal diagnosis of
CHD or if immediate admission to a neonatal in-
tensive care unit had been necessary, is not known
either. No conclusion about the screening’s im-
pact on the detection rate of CHD can be de-
duced from the analysed data. However, this was
not the aim of this study. 
Conclusion
Three years after nationwide PO screening
was recommended, most Swiss maternity units
have implemented this screening in their current
management protocol for neonates. The imple-
mentation of this protocol has not caused any sig-
nificant difficulties. The current screening strat-
egy has led to 85% of all neonates born in
Switzerland being tested. The negative outlook of
maternity units which do not perform the screen-
ing is not based on evidence but on structural and
financial considerations. Further efforts are
needed to convince all maternity units in Switzer-
land of the need for the screening. Special atten-
tion ought to be paid to smaller units and to
birthing centres, given their limited range of
available equipment and specially trained staff to
treat neonates with CHD if needed.
We are grateful to all the maternity units which par-
ticipated in this study for their cooperation. In addition,
we would like to thank Clare Jackson for her valuable
help in polishing the English.
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